Vitiligo after the resolution of psoriatic plaques during treatment with adalimumab - 24/04/13
Doi : 10.1016/j.jaad.2006.05.035
David I. Smith, MD a, Michael P. Heffernan, MD b, ⁎ 
a Divisions of Dermatology, Washington University School of Medicine, Saint Louis, Missouri
b Wright State University School of Medicine, Dayton, Ohio
Reprint requests: Michael P. Heffernan, MD, Division of Dermatology, Wright State University School of Medicine, One Elizabeth Place, Suite 200, Dayton, OH 45408-1445| Dr Heffernan was previously affiliated with Washington University School of Medicine |
|
| Funding sources: None. |
|
| Disclosure: Dr Heffernan, Dr Smith, and/or the Washington University School of Medicine Dermatology Clinical Trials Unit have been active in industry-sponsored research with Abbott Immunologies and Humira’s competitors, including: Amgen, Biogen, Genentech, and Centocor. |
© 2008
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 58 - N° 2S1
P. S50-S52 - février 2008 Retour au numéro
Article précédent
- Segmental porokeratosis after radiation therapy for follicular lymphoma
- Alaina J. James, Loren E. Clarke, Rosalie Elenitsas, Kenneth Katz
- Pyogenic granuloma and pemphigus vulgaris: An unusual association
- Jacob Dudelzak, Jack L. Lesher, Rafik A. Abdelsayed
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?